CATALOGO DEI PRODOTTI DELLA RICERCA

IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.

Benvenuti in IRIS!

IRIS è l'archivio istituzionale Open Access destinato a raccogliere, conservare e rendere visibile la produzione scientifica dell'Università degli Studi di Verona.
È possibile inserire nuovi prodotti o integrare i dati di quelli già inseriti, accedendo a IRIS (pulsante Login in alto a destra) con le proprie credenziali GIA.
Guide e video tutorial sono disponibili a questo link.

Per ricevere supporto scrivere all'indirizzo catalogo.ricerca@ateneo.univr.it

Prodotti recenti

The impact of managed entry agreements on pharmaceutical prices

Managed entry agreements (MEAs) have been used for several years, with the aim of curbing the growth of pharmaceutical expenditure and enhancing patient access to innovation. Yet, much remains to be understood about their economic implications. This paper studies the impact of MEAs ...

Word, Phrase, and Sentence in Relation - Ancient Grammars

The contributions contained in this volume offer a multidisciplinary approach into the history of the parts of speech and their role in building phrases and sentences. They fulfill a current interest for syntactic problems for combining recent linguistic theories with the long tradition...

Clause relations in Ancient Greek Grammatical tradition?

The paper presents some considerations on the use and meaning of some terms in the Ancient Greek grammatical and rhetorical tradition with reference to the metalinguistic sphere of the syntax. In a recent study on the use and distribution of the ancient terms σύνταξις, σύνθεσι...

A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib

Background: Patients with glioblastoma (GBM) have a dramatically poor prognosis. The recent REGOMA trial suggested an overall survival benefit of regorafenib in recurrent GBM patients. Considering the extreme genetic heterogeneity of GBMs, we aimed to identify molecular biomarkers predictive of d...

Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations

Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations.

CATALOGO DEI PRODOTTI DELLA RICERCA

Benvenuti in IRIS!

Prodotti recenti

The impact of managed entry agreements on pharmaceutical prices

Word, Phrase, and Sentence in Relation - Ancient Grammars

Clause relations in Ancient Greek Grammatical tradition?

A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib

Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations

Scopri